These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34455476)

  • 1. Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders.
    Masuda H; Mori M; Yokouchi H; Uzawa A; Uchida T; Muto M; Ohtani R; Aoki R; Yamamoto S; Kuwabara S
    J Neurol; 2022 Apr; 269(4):1996-2003. PubMed ID: 34455476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
    Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
    Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
    Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
    Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
    Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
    Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.
    Stiebel-Kalish H; Rubarth K; Shouchane-Blum K; Tiosano A; Lotan I; Hellmann MA; Wilf-Yarkoni A; Bialer O; Flanagan EP; Pittock SJ; Bhatti MT; Schmitz-Hübsch T; Paul F; Asseyer S; Chen JJ
    Sci Rep; 2022 Dec; 12(1):21312. PubMed ID: 36494385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Bribiesca Contreras E; Gómez-Figueroa E; Flores-Rivera J; Correa-Díaz EP; Toral Granda AM; Ortiz Yepez MA; Gualotuña Pachacama WA; Piedra Andrade JS; Galleguillos L; Tkachuk V; Nadur D; Daccach Marques V; Soto de Castillo I; Casas M; Cohen L; Alonso R; Caride A; Lana-Peixoto M; Rojas JI
    Eur J Neurol; 2022 Mar; 29(3):802-809. PubMed ID: 34799965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
    Gericke FC; Hanson JVM; Hackenberg A; Gerth-Kahlert C
    Eur J Paediatr Neurol; 2024 Jan; 48():113-120. PubMed ID: 38217965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of first-ever episode of severe optic neuritis.
    Galetta K; Ryan S; Manzano G; Chibnik LB; Balaban D; Prasad S; Chwalisz BK; Salazar-Camelo A; Conway S; Levy M; Matiello M
    Mult Scler Relat Disord; 2022 Oct; 66():104020. PubMed ID: 35839615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].
    Song HL; Wei SH
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683
    [No Abstract]   [Full Text] [Related]  

  • 10. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
    Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
    Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
    Chen JJ; Bhatti MT
    Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
    Kaushik M; Burdon MA
    J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
    Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
    Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
    Gospe SM; Chen JJ; Bhatti MT
    Eye (Lond); 2021 Mar; 35(3):753-768. PubMed ID: 33323985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features.
    Zhao J; Chen X; Zhang J; Liu L; Wang J; Zhu L
    Mult Scler Relat Disord; 2024 May; 85():105518. PubMed ID: 38447395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
    J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.
    Dauby S; Dive D; Lutteri L; Andris C; Hansen I; Maquet P; Lommers E
    Acta Neurol Belg; 2022 Feb; 122(1):135-144. PubMed ID: 34097296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.
    Tajfirouz DA; Bhatti MT; Chen JJ
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease.
    Wang J; Yang K; Zhang F; Yi Y; Wang J
    Mult Scler Relat Disord; 2023 Sep; 77():104879. PubMed ID: 37442076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Details and outcomes of a large cohort of MOG-IgG associated optic neuritis.
    Chen JJ; Flanagan EP; Bhatti MT; Tisavipat N; Jamali S; Kunchok A; Eggenberger ER; Nome MD; Sotirchos ES; Vasileiou ES; Henderson AD; Arnold AC; Bonelli L; Seleme N; Mejia-Vergara AJ; Moss HE; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Wilf-Yarkoni A; Hellmann MA; Vuppala A; Hodge D; Pittock SJ
    Mult Scler Relat Disord; 2022 Dec; 68():104237. PubMed ID: 36252317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.